Equities

Vapotherm Inc

VAPO:QXR

Vapotherm Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.80
  • Today's Change0.00 / 0.00%
  • Shares traded3.00
  • 1 Year change-83.87%
  • Beta-1.3175
Data delayed at least 15 minutes, as of Jun 10 2024 14:30 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Vapotherm, Inc. is a developer and manufacturer of advanced respiratory technology. It develops non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. It is focused on the care of patients suffering from respiratory distress, whether associated with lung diseases, such as chronic obstructive pulmonary disease, congestive heart failure, pneumonia, asthma, and COVID-19 or other systemic conditions. Its device solutions are focused on High Velocity Nasal Insufflation, which delivers non-invasive ventilatory support to patients by providing heated, humidified, oxygenated air at high velocities through a small-bore nasal interface, and on closed loop control systems, such as its Oxygen Assist Module, designed to automatically maintain a patients pulse oxygen saturation levels within a specified range for a defined period of time. Its digital solutions are focused on remote patient monitoring, using algorithms to predict respiratory episodes.

  • Revenue in USD (TTM)70.07m
  • Net income in USD-54.94m
  • Incorporated2013
  • Employees182.00
  • Location
    Vapotherm Inc100 Domain DriveEXETER 03833United StatesUSA
  • Phone+1 (603) 658-0411
  • Fax+1 (302) 636-5454
  • Websitehttps://vapotherm.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Avinger Inc7.62m-16.13m3.46m68.00------0.4533-18.16-18.167.49-2.560.40841.206.38112,102.90-102.83-70.93---131.5722.4330.87-251.78-208.910.4764-10.021.38---7.51-0.673632.76---24.21--
Heart Test Laboratories Inc18.60k-6.39m3.64m12.00--40.89--195.63-0.4912-0.49120.00090.13570.00260.0092.531,550.00-89.51---120.71--67.31---34,362.42--4.70-16.410.0547---64.16---31.61------
Catheter Precision Inc439.00k-6.85m3.71m14.00--0.2004--8.46-1.03-1.030.06592.450.01150.37595.7431,357.14-17.89---19.64--94.31---1,559.68--0.8047--0.004--3,057.14---165.67------
Nu-Med Plus Inc0.00-119.16k3.85m2.00---------0.0014-0.00140.00-0.0020.00----0.00-350.01-447.69---------------22.74--------3.56------
SINTX Technologies Inc2.78m-8.88m4.06m43.00--0.0173--1.46-389.94-389.9474.21383.240.1381.625.8464,534.88-44.03-45.71-57.11-57.3667.9658.47-318.99-681.801.67--0.0229--68.2994.2449.75--54.10--
Nuwellis Inc8.90m-19.93m4.11m59.00--1.75--0.4623-8.30-8.302.730.13040.70761.557.04150,762.70-143.62-98.07-216.07-122.4857.4155.22-202.97-230.510.7092-4.750.00--3.7612.14-55.78--4.61--
Therapeutic Solutions International Inc98.99k-2.17m4.13m3.00--3.04--41.75-0.0007-0.00070.000030.00030.02871.134.4432,996.67-64.51-162.32-169.11--62.8567.79-2,247.41-2,391.850.0333-4.920.373---52.1395.3543.11------
Vapotherm Inc70.07m-54.94m4.43m182.00------0.0632-8.62-8.6211.00-11.020.81221.467.53385,011.00-63.68-49.73-587.27-62.5445.2843.56-78.40-78.990.1259-1.272.59--2.8010.1448.62---10.38--
Arch Therapeutics Inc130.55k-8.43m4.49m8.00------34.38-3.68-3.680.0425-2.450.08330.0637--16,318.75-538.25-188.28---804.6333.37---6,458.14-26,945.920.0164-1.27----383.83---32.35---21.76--
ADM Tronics Unlimited Inc2.85m-716.86k4.74m7.00--4.30--1.67-0.0106-0.01060.04210.01630.97723.854.25---24.62-11.45-38.81-15.7738.4543.73-25.19-15.281.24--0.2902--14.66-0.415993.04------
Pressure Biosciences Inc2.27m-29.56m4.76m15.00------2.09-1.70-1.700.1299-1.221.022.289.17151,505.30-1,074.63-643.54----6.8934.75-1,050.30-798.210.0185-0.4182-----13.64-5.0521.52---34.47--
Bioelectronics Corp1.61m-289.82k4.94m9.00------3.07-0.00002-0.000020.00007-0.00066.329.2014.53---113.86-383.59----49.4351.48-18.01-143.480.0099-0.4909----94.01-5.0975.01------
Nexalin Technology Inc158.86k-4.94m5.09m6.00--2.19--32.07-0.6676-0.66760.02150.31290.03630.177844.0126,476.67-112.76---139.94--82.54---3,110.58--4.75--0.00---91.62---173.80------
BIOLASE Inc48.83m-38.26m5.14m157.00------0.1053-20.50-20.508.640.00811.282.219.00311,006.40-55.75-49.28-118.58-85.8034.2535.27-43.56-50.720.6409-5.980.9812--1.451.27-30.39--18.63--
Sharps Technology Inc0.00-8.71m5.27m3.00--0.7677-----0.6204-0.62040.000.43780.00-------74.67---95.84----------0.492--0.00-------112.12------
Guided Therapeutics Inc82.00k-3.23m5.57m4.00------67.91-0.0623-0.06230.0016-0.07210.03740.090411.7120,500.00-137.80-136.13----32.9329.39-3,685.37-3,666.670.1138-11.13----653.8511.4524.40------
Data as of Jun 10 2024. Currency figures normalised to Vapotherm Inc's reporting currency: US Dollar USD

Institutional shareholders

52.67%Per cent of shares held by top holders
HolderShares% Held
Roystone Capital Management LPas of 31 Dec 2023647.56k10.46%
Armistice Capital LLCas of 22 Apr 2024568.84k9.18%
Crow's Nest Holdings LPas of 31 Dec 2023561.00k9.06%
Kent Lake Capital LLCas of 31 Dec 2023499.62k8.07%
Millennium Management LLCas of 31 Dec 2023490.04k7.91%
Parian Global Management LPas of 31 Dec 2023408.94k6.60%
Taylor Frigon Capital Management LLCas of 29 Feb 202449.36k0.80%
Bridgeway Capital Management LLCas of 31 Mar 202418.69k0.30%
Ridgeview Smith Investments LLCas of 30 Sep 202317.13k0.28%
Pennsylvania State Employees' Retirement Systemas of 31 Dec 20211.25k0.02%
More ▼
Data from 31 Dec 2021 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.